Best Medical Stocks To Consider - November 21st

Gilead Sciences logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Gilead Sciences, McKesson, and Medtronic were identified as medical stocks with the highest recent dollar trading volume.
  • Gilead develops medicines, including treatments for HIV/AIDS and viral hepatitis; its shares slipped to $166.33 on Friday. McKesson distributes pharmaceuticals and healthcare products, and its shares rose to $1,069.31.
  • Medtronic makes medical devices and therapies, including cardiovascular products. Its shares fell to $99.88 on Friday.
  • MarketBeat previews the top five stocks to own by December 1st.

Gilead Sciences, McKesson, and Medtronic are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies that develop, make, or provide medical and healthcare products and services, such as pharmaceuticals, biotechnology, medical devices, and healthcare services. Investors may buy them to gain exposure to the healthcare sector, though their performance can be affected by factors such as regulation, research results, and changes in demand. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Gilead Sciences (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

NASDAQ:GILD traded down $0.20 during mid-day trading on Friday, reaching $166.33. The stock had a trading volume of 7,554,884 shares, compared to its average volume of 6,456,805. The company has a debt-to-equity ratio of 1.84, a current ratio of 1.38 and a quick ratio of 1.22. Gilead Sciences has a 12 month low of $116.88 and a 12 month high of $176.58. The stock has a market capitalization of $206.30 billion, a PE ratio of -52.64 and a beta of 0.35. The stock has a 50-day simple moving average of $157.26 and a two-hundred day simple moving average of $142.46.

Read Our Latest Research Report on GILD

McKesson (MCK)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Shares of McKesson stock traded up $7.15 during midday trading on Friday, hitting $1,069.31. 869,451 shares of the company traded hands, compared to its average volume of 719,145. The firm's fifty day moving average price is $974.65 and its 200-day moving average price is $880.71. The stock has a market cap of $123.46 billion, a price-to-earnings ratio of 27.50, a PEG ratio of 1.87 and a beta of 0.27. McKesson has a 12 month low of $723.68 and a 12 month high of $1,121.50.

Read Our Latest Research Report on MCK

Medtronic (MDT)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

MDT stock traded down $0.73 during midday trading on Friday, reaching $99.88. 9,033,491 shares of the stock were exchanged, compared to its average volume of 8,120,876. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.07 and a quick ratio of 1.54. The stock has a market capitalization of $127.75 billion, a PE ratio of 24.60, a P/E/G ratio of 2.41 and a beta of 0.56. Medtronic has a 52 week low of $73.31 and a 52 week high of $106.33. The company has a fifty day moving average price of $94.62 and a 200 day moving average price of $88.45.

Read Our Latest Research Report on MDT

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Gilead Sciences Right Now?

Before you consider Gilead Sciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gilead Sciences wasn't on the list.

While Gilead Sciences currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines